Details for New Drug Application (NDA): 062730
✉ Email this page to a colleague
NDA 062730 describes CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in two NDAs. Additional details are available on the CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER profile page.
The generic ingredient in CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
The generic ingredient in CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Summary for 062730
| Tradename: | CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare |
| Ingredient: | cephalothin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062730
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 20MG BASE/ML | ||||
| Approval Date: | Mar 5, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 40MG BASE/ML | ||||
| Approval Date: | Mar 5, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
